Acronym

PDAC - Pancreatic Ductal Adenocarcinoma

Pancreatic Ductal Adenocarcinoma

Most common pancreatic malignancy; aggressive with poor prognosis

Expansion

Pancreatic Ductal Adenocarcinoma

Purpose

Computed tomography shows hypodense mass, typically head; usually advanced at diagnosis

Clinical Context

Pancreatic ductal adenocarcinoma: adenocarcinoma, aggressive. Computed tomography shows hypodense mass with loss of fat plane. Often metastatic at diagnosis. Median survival approximately 11 months.

  • Pancreatic cancer
  • Gastrointestinal malignancy

Key Points

  • “Pancreatic ductal adenocarcinoma: hypodense mass on computed tomography, focal ductal dilatation, enlarged lymph nodes; 5-year survival approximately 10 percent”